Baricitinib associated with significant improvement in RA
(HealthDay)—For patients with rheumatoid arthritis who have had an inadequate response to methotrexate, baricitinib is associated with significant clinical improvements, compared to either placebo or adalimumab, according ...
Feb 20, 2017
0
0